Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Conyers

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Cancers|April 14, 2025
Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond TreatmentClare Parker, Clarissa E Schilstra, Karen McCleary, et al.
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT<sub>3</sub> Receptor Antagonists: 2026 UpdateClaire Moore, Melissa S Bourque, Andreas Halman, et al.
Transplantation and Cellular Therapy|February 8, 2025
Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell TransplantHannah Walker, Lorna McLeman, Deborah Meyran, et al.
Genetics in Medicine Open|January 16, 2026
Clinical and genetic spectrum of Fanconi anemia in Australia and New ZealandHannah Fluhler, Elissah Granger, Michael Sharp, et al.
BMC Cancer|September 15, 2022
Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemiaClarissa E Schilstra, Karen McCleary, Joanna E Fardell, et al.
Blood Advances|November 19, 2025
Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editingLu Liu, Astrid Glaser, Abdulsalam I Isiaku, et al.
JACC. Advances|June 28, 2024
Cardio-Oncology Recommendations for Pediatric Oncology Patients: An Australian and New Zealand Delphi ConsensusClaudia Toro, Ben Felmingham, Sophie Jessop, et al.
The Medical Journal of Australia|May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidanceRobert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Cancers|April 14, 2025
Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond TreatmentClare Parker, Clarissa E Schilstra, Karen McCleary, et al.
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT<sub>3</sub> Receptor Antagonists: 2026 UpdateClaire Moore, Melissa S Bourque, Andreas Halman, et al.
Transplantation and Cellular Therapy|February 8, 2025
Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell TransplantHannah Walker, Lorna McLeman, Deborah Meyran, et al.
Genetics in Medicine Open|January 16, 2026
Clinical and genetic spectrum of Fanconi anemia in Australia and New ZealandHannah Fluhler, Elissah Granger, Michael Sharp, et al.
BMC Cancer|September 15, 2022
Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemiaClarissa E Schilstra, Karen McCleary, Joanna E Fardell, et al.
Blood Advances|November 19, 2025
Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editingLu Liu, Astrid Glaser, Abdulsalam I Isiaku, et al.
JACC. Advances|June 28, 2024
Cardio-Oncology Recommendations for Pediatric Oncology Patients: An Australian and New Zealand Delphi ConsensusClaudia Toro, Ben Felmingham, Sophie Jessop, et al.
The Medical Journal of Australia|May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidanceRobert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Pageof 7